Dr. Carol Eisenstat, a board-certified physician and founder of Line Eraser MD, was recently featured in Daily Mail in a report examining the growing trend known as “GLP-1 stacking.”
The term describes combining or overlapping different weight-loss medications in an attempt to accelerate weight loss, overcome a plateau or achieve stronger results. The Daily Mail report highlights growing medical concern about people experimenting with these medications without an individualized treatment plan. The feature was published on July 29, 2026.
Why GLP-1 Medications Should Not Be Mixed Independently
Medications such as semaglutide and tirzepatide influence appetite, digestion, blood sugar and feelings of fullness. Combining medications or changing doses without clinical supervision does not necessarily produce better results and may increase the likelihood of side effects or dosing mistakes.
The FDA has previously received reports of serious adverse events associated with semaglutide dosing errors, including cases requiring medical attention or hospitalization. Reported complications have included nausea, vomiting, abdominal pain, dehydration, fainting, pancreatitis and gallstones.
Switching Is Not the Same as Stacking
A medical provider may recommend changing from one GLP-1 medication to another when progress, tolerance or a patient’s health needs justify it. However, a supervised transition is different from independently taking two medications together.
Patients considering a change can read Line Eraser MD’s guide to switching from semaglutide to tirzepatide. Any change should be based on medical history, current dosage, side effects and an appropriate transition plan.
The Importance of Medically Supervised Weigaht Loss
Line Eraser MD’s Slim MD weight-loss program provides individualized medication planning, ongoing monitoring and body-composition assessments for patients using semaglutide or tirzepatide.
The goal is not simply to increase medication exposure. It is to identify a safe and sustainable plan that supports fat loss while protecting the patient’s wider health.
Read the Full Feature
Read the complete article on Daily Mail.
